Download presentation
Presentation is loading. Please wait.
1
European Neuropsychopharmacology
Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders Charlotte Skoglund, Lena Brandt, Brian D’Onofrio, Henrik Larsson, Johan Franck European Neuropsychopharmacology DOI: /j.euroneuro Copyright © Terms and Conditions
2
Fig. 1 Flowchart. European Neuropsychopharmacology DOI: ( /j.euroneuro ) Copyright © Terms and Conditions
3
Fig. 2 Mean methylphenidate doses over time in individuals with SUD compared to individuals with ADHD only. SUD=Substance use disorder, SUD=Individuals with comorbid Substance use disorder who have been prescribed methylphenidate, No SUD=Individuals with ADHD only who have been prescribed methylphenidate. European Neuropsychopharmacology DOI: ( /j.euroneuro ) Copyright © Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.